Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein kinase 1 alpha 1 like (CSNK1A1L) is a serine/threonine protein kinase belonging to the CK1 family, involved in signal transduction, negative regulation of canonical Wnt signaling, and phosphorylation of various substrate proteins. It localizes primarily to the cytoplasm and nucleus, and its function has been implicated in the regulation of β-catenin stability, cell cycle progression, and potentially in the modulation of p53 and NF-κB signaling. CSNK1A1L is associated with multiple physiological processes and disease states, such as cancer, neurodegeneration (Alzheimer's disease), and hematologic malignancies. Although not as extensively studied as the closely related CSNK1A1 (CK1α), this kinase shares key functional, substrate, and regulatory features within the CK1 family, suggesting a potential as a drug target and biomarker in relevant contexts
Ubiquitination and proteasomal degradation of the kinase (e.g., by lenalidomide); Direct kinase inhibition (e.g., by small-molecule inhibitors like D4476)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein kinase 1 alpha 1 like (CSNK1A1L).